Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
CHA University
CHA University
CHA University
Centre Oscar Lambret
Institute of Oncology Ljubljana
Institute of Oncology Ljubljana
The Institute of Molecular and Translational Medicine, Czech Republic
Dana-Farber Cancer Institute
National University Hospital, Singapore
Boehringer Ingelheim
Boston Children's Hospital
City of Hope Medical Center
University Health Network, Toronto
IRCCS San Raffaele
Jewish General Hospital
Rigshospitalet, Denmark
M.D. Anderson Cancer Center
City of Hope Medical Center
Centre Jean Perrin
University of Southern California
CHA University
Erasmus Medical Center
SOLTI Breast Cancer Research Group
University Hospital, Montpellier
University Hospital, Montpellier
Gustave Roussy, Cancer Campus, Grand Paris
Huashan Hospital
SOLTI Breast Cancer Research Group
Helse Nord-Trøndelag HF
University of Wisconsin, Madison
University Hospital, Ghent
Ludwig-Maximilians - University of Munich
Fundacion Clinic per a la Recerca Biomédica
Fundacion Clinic per a la Recerca Biomédica
Case Comprehensive Cancer Center
Universiteit Antwerpen
University of Arizona
University Health Network, Toronto
Assistance Publique - Hôpitaux de Paris
Australian & New Zealand Children's Haematology/Oncology Group
Karolinska University Hospital
University Hospital, Montpellier
Xinqiao Hospital of Chongqing
UMC Utrecht
Oncology Institute of Southern Switzerland
University Hospital, Montpellier
University of Milano Bicocca
Corporacion Parc Tauli
Centro di Riferimento Oncologico - Aviano
Nanfang Hospital, Southern Medical University